Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
Clinical trial NCT03386305 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03386305
- Sponsor
- Albert Einstein Healthcare Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2021-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.